Evaluation of neoadjuvant weekly nanoparticle albumin-bound paclitaxel for HER2-negative breast cancer

被引:1
|
作者
Nagayama, A. [1 ]
Matsui, A. [1 ]
Tachibana, A. [2 ]
Suzuki, N. [3 ]
Hirata, M. [4 ]
Oishi, Y. [5 ]
Hamaguchi, Y. [6 ]
Murata, Y. [7 ]
Okamoto, Y. [8 ]
机构
[1] Natl Hosp Org, Tokyo Med Ctr, Surg, Tokyo, Japan
[2] Mutual Aid Assoc Publ Sch Teachers, Kanto Cent Hosp, Breast Surg, Tokyo, Japan
[3] Omori Red Cross Hosp, Breast Surg, Tokyo, Japan
[4] JR Tokyo Gen Hosp, Breast Surg, Tokyo, Japan
[5] Nissan Tamagawa Hosp, Breast Surg, Tokyo, Japan
[6] Futakotamagawa Breast Clin, Breast Surg, Tokyo, Japan
[7] Natl Hosp Org, Tokyo Med Ctr, Pathol, Tokyo, Japan
[8] Toho Univ, Breast Surg, Med Ctr, Ohashi Hosp, Tokyo, Japan
关键词
D O I
10.1093/annonc/mdw365.75
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
296P
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Efficacy comparisons of solvent-based paclitaxel, liposomal paclitaxel, nanoparticle albumin-bound paclitaxel, and docetaxel after neoadjuvant systemic treatment in breast cancer
    Zhang, Weiwei
    Wang, Ye
    He, Jinzhi
    Xu, Yinggang
    Chen, Rui
    Wan, Xinyu
    Shi, Wenjie
    Huang, Xiaofeng
    Xu, Lu
    Wang, Jue
    Zha, Xiaoming
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2023, 54
  • [42] Phase I study of combination therapy with weekly nanoparticle albumin-bound paclitaxel and cyclophosphamide in patients with advanced or recurrent breast cancer
    Ota, D.
    Akatsuka, S.
    Nishi, T.
    Kato, T.
    Takeuchi, M.
    Munechika, T.
    Inagaki, M.
    Fukuuchi, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S283 - S283
  • [43] Phase II Trial of Weekly Nanoparticle Albumin-Bound Paclitaxel With Carboplatin and Trastuzumab as First-line Therapy for Women With HER2-Overexpressing Metastatic Breast Cancer
    Conlin, Alison K.
    Seidman, Andrew D.
    Bach, Ariadne
    Lake, Diana
    Dickler, Maura
    D'Andrea, Gabriella
    Traina, Tiffany
    Danso, Michael
    Brufsky, Adam M.
    Saleh, Mansoor
    Clawson, Alicia
    Hudis, Clifford A.
    CLINICAL BREAST CANCER, 2010, 10 (04) : 281 - 287
  • [44] Phase II study of neoadjuvant bevacizumab and trastuzumab administered with albumin-bound paclitaxel (nab paclitaxel) and carboplatin in HER2+locally advanced breast cancer
    Raefsky, E.
    Castillo, R.
    Lahiry, A.
    Thompson, D. S.
    Hanson, S.
    Meng, C.
    Knauer, D.
    Trieu, V.
    Desai, N.
    Yardley, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [45] Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer
    von Minckwitz, Gunter
    Eidtmann, Holger
    Rezai, Mahdi
    Fasching, Peter A.
    Tesch, Hans
    Eggemann, Holm
    Schrader, Iris
    Kittel, Kornelia
    Hanusch, Claus
    Kreienberg, Rolf
    Solbach, Christine
    Gerber, Bernd
    Jackisch, Christian
    Kunz, Georg
    Blohmer, Jens-Uwe
    Huober, Jens
    Hauschild, Maik
    Fehm, Tanja
    Mueller, Berit Maria
    Denkert, Carsten
    Loibl, Sibylle
    Nekljudova, Valentina
    Untch, Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (04): : 299 - 309
  • [46] Randomized phase II trial of three dosing schedules of nanoparticle albumin-bound paclitaxel with bevacizumab as first-line therapy for HER2-negative metastatic breast cancer: An initial interim safety report
    Conlin, A. K.
    Seidman, A. D.
    Moynahan, M. E.
    Traina, T.
    Mace, J. R.
    Meiri, E.
    Bach, A.
    Edwards, C.
    Hudis, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [47] Management of breast cancer with nanoparticle albumin-bound (nab)-paclitaxel combination regimens: A clinical review
    Chirgwin, J.
    Chua, S. L.
    BREAST, 2011, 20 (05): : 394 - 406
  • [48] Antitumor activity of nanoparticle albumin-bound paclitaxel in experimental gastric cancer
    Zhang, Changhua
    Ostapoff, Katherine T.
    Awasthi, Niranjan
    Schwarz, Margaret A.
    Schwarz, Roderich
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [49] Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer
    G. Roviello
    F. U. Conter
    E. Mini
    D. Generali
    M. Traversini
    D. Lavacchi
    S. Nobili
    N. Sobhani
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 669 - 677
  • [50] Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer
    Roviello, G.
    Conter, F. U.
    Mini, E.
    Generali, D.
    Traversini, M.
    Lavacchi, D.
    Nobili, S.
    Sobhani, N.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (04) : 669 - 677